Arlocabtagene Autoleucel
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Arlocabtagene Autoleucel, covering 2026-02-10 to 2026-02-18. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma [Phase 1]